Tag: treatment

The World Health Organization (WHO) has issued new recommendations on how to organise services in order to promote linkage to care and retention in care as part of its new guidelines recommending antiretroviral treatment for all adults and adolescents. The recommendations on antiretroviral treatment and for pre-exposure prophylaxis for people at substantial risk of HIV… Read more »

CATIE Treatment Update 207

  I HEPATITIS C VIRUS About some terms – SVR12 vs. SVR24 SVR linked to longer survival and other benefits Issues with emerging therapies for HCV Simeprevir + sofosbuvir – experience in the clinic Holkira Pak approved in Canada for genotype 1 Holkira Pak – results in genotype 1a without severe liver injury Holkira Pak… Read more »

Study uncovers new ground about when to start HIV therapy A major question that has recurred since the availability of potent combination anti-HIV therapy (commonly called ART or HAART) is when this therapy should be initiated to ensure the optimal health of HIV-positive people. New research has revealed that early therapy may be highly beneficial…. Read more »

CATIE Treatment Update 205 – November 2014

Inflammation and its discontents When cells of the immune system encounter invading germs they can become activated and enter into a heightened state of alert. Temporary inflammation during short-lived infections is useful for marshalling the immune response. However, chronic inflammation from an ongoing infection—such as that arising from HIV—can injure organ-systems, causing them to slowly… Read more »

HepCBC’s December Bulletin

Before reading this newsletter, HepCBC is asking for you and your friends to help make hepatitis C drugs more accessible and affordable. You can do so by answering a few simple questions to help HepCBC make a great Patient group Input submission to CADTH (Canadian Agency for Drugs and Technologies in Health) about the value… Read more »

CATIE: HepCinfo Update 5.23

New and Noteworthy Harvoni (ledipasvir + sofosbuvir) approved by Health Canada In October, Health Canada approved the hepatitis C medication Harvoni (ledipasvir + sofosbuvir) for people over the age of 18 with genotype 1 hepatitis C virus. In clinical trials, the cure rate for this combination was 94% to 100%. Ledipasvir and sofosbuvir are both… Read more »

CATIE’s HepCInfo Update 5.1

New and Noteworthy Montreal study shows testing positive for hepatitis C linked to decreased injection drug use People who inject drugs and who test positive for hepatitis C were more likely to decrease their drug use then people who tested negative, reported researchers in Clinical Infectious Diseases. From 2004 to 2011, the University of Montreal… Read more »

Developing Public Awareness Messaging about HIV Testing

The Public Health Agency of Canada recently held 2 webinars on Developing Public Awareness Messaging about HIV Testing. The 3 topics presented were: HIV Testing Guide HIV Testing Rates in Canada HIV Estimates   Prevention, support and treatment resources CANADIAN AIDS TREATMENT INFORMATION EXCHANGE (CATIE) CATIE is Canada’s source for up-to-date information about HIV and… Read more »